Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital

被引：10

作者：

Acikgoz, ZC

Almayanlar, E

Gamberzade, S

Gocer, S

机构：

[1] Fatih Univ Hatanesi, Fatih Univ Fac Med, Dept Microbiol & Clin Microbiol, TR-06510 Ankara, Turkey

[2] METIS Biotechnol Ltd, Ankara, Turkey

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 04期

关键词：

D O I：

10.1128/AAC.48.4.1410-1412.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Macrolide resistance in 156 consecutive group B streptococcal isolates was investigated. Thirty-five isolates (22.4%) had inducible (80%) or constitutive (20%) erythromycin resistance. The genes responsible were erm(B), erm(A) subclass erm(TR), and erm(B) plus erm(TR) in 62.9, 2.9, and 8.6% of isolates, respectively. Nine isolates (25.7%) harbored neither mef nor detectable erm genes.

引用

收藏

页码：1410 / 1412

页数：3

相关论文

共 13 条

[1] Macrolide resistance determinants of group A streptococci in Ankara, Turkey [J].

Acikgoz, ZC ;

Gocer, S ;

Tuncer, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :110-112

[2] High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes:: results of a Spanish multicentre study in 1998 [J].

Alós, JI ;

Aracil, B ;

Oteo, J ;

Torres, C ;

Gómez-Garcés, JL .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :605-609

[3]

AZAVEDO JC, 2001, ANTIMICROB AGENTS CH, V45, P3504

[4] Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].

Bingen, E ;

Fitoussi, F ;

Doit, C ;

Cohen, R ;

Tanna, A ;

George, R ;

Loukil, C ;

Brahimi, N ;

Le Thomas, I ;

Deforche, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457

[5] Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae [J].

Culebras, E ;

Rodriguez-Avial, I ;

Betriu, C ;

Redondo, M ;

Picazo, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1574-1576

[6] Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae:: French multicenter study [J].

De Mouy, D ;

Cavallo, JD ;

Leclercq, R ;

Fabre, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2400-2402

[7] In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002 [J].

Ergin, A ;

Ercis, S ;

Hasçelik, G .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (02) :160-163

[8] Mechanisms of macrolide resistance in clinical group B streptococci isolated in France [J].

Fitoussi, F ;

Loukil, C ;

Gros, I ;

Clermont, O ;

Mariani, P ;

Bonacorsi, S ;

Le Thomas, I ;

Deforche, D ;

Bingen, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1889-1891

[9] Erythromycin resistance genes in group A streptococci in Finland [J].

Kataja, J ;

Huovinen, P ;

Skurnik, M ;

Seppälä, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) :48-52

[10] Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations [J].

Malbruny, B ;

Nagai, K ;

Coquemont, M ;

Bozdogan, B ;

Tambic Andrasevic, A ;

Hupkova, H ;

Leclercq, R ;

Appelbaum, PC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) :935-939